EverSource Wealth Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-143
Closed -$47.2K 3173
2024
Q1
$47.2K Buy
143
+8
+6% +$1.96K ﹤0.01% 1005
2023
Q4
$25.7K Sell
135
-20
-13% -$3.78K ﹤0.01% 1130
2023
Q3
$30.9K Buy
155
+116
+297% +$27.4K ﹤0.01% 971
2023
Q2
$11.1K Buy
39
+9
+30% +$2.5K ﹤0.01% 1390
2023
Q1
$6.5K Buy
+30
New +$5.84K ﹤0.01% 1550
2022
Q4
Sell
-4
Closed -$1K 2452
2022
Q3
$1K Buy
+4
New +$1.02K ﹤0.01% 1942
2022
Q1
Sell
-6
Closed -$1K 1888
2021
Q4
$1K Buy
+6
New +$1.18K ﹤0.01% 1750

Other funds holding SWAV

EverSource Wealth Advisors's SWAV Position: Q2 2024 in Review

EverSource Wealth Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 143 shares — an estimated $47.2K sold.

EverSource Wealth Advisors first reported a position in SWAV in Q4 2021 and held it in 7 quarters. The position peaked at $47.2K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • EverSource Wealth Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • EverSource Wealth Advisors sold 143 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $47.2K.
  • EverSource Wealth Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • EverSource Wealth Advisors's Shockwave Medical, Inc. Common Stock position peaked at $47.2K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on EverSource Wealth Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.